Ian Ingram, PharmD, BCOP

an oncology pharmacist

Ian Ingram, PharmD, BCOP, is an oncology pharmacist at Providence Portland Medical Center, where his practice focuses on the management of toxicities associated with antibody-drug conjugates. His work examines how pharmacogenomics and institutional dosing policies intersect to affect real-world patient outcomes.

Published Articles (1)

A Hidden Dosing Trap in Antibody-Drug Conjugates: How Weight-Based Rounding Can Silently Double a Dose Increase

October 16, 2026

A delayed neutropenia case reveals how UGT1A1 metabolizer status and weight-based dose rounding can silently double a sacituzumab dose error.